Cargando…
A Granulomatous Drug Eruption Induced by Entecavir
Entecavir (Baraclude®, Bristol-Myers Squibb) is a potent and selective antiviral agent that has demonstrated efficacy in patients with chronic hepatitis B. The most frequent adverse events attributed to entecavir include increased alanine aminotransferase, upper respiratory tract infection, headache...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870221/ https://www.ncbi.nlm.nih.gov/pubmed/24371400 http://dx.doi.org/10.5021/ad.2013.25.4.493 |